Organogenesis holds the distinction of being the first company to gain FDA approval for a mass-produced product containing living human cells. Recent achievements include: Apligraf is now being reimbursed by Medicare in all 50 states. Launch of two products – FortaPerm TM and FortaGen TM – by our newly -formed sales and marketing team. Realigning of our resources to focus on two core areas – living wound healing products and bioengineered surgical products. Marketing clearance gained for rotator cuff repair patch, to be marketed by Biomet, Inc.